Does an Exclusive-Dealing Agreement Violate the Antitrust Laws?
By: Jarod Bona (The Antitrust Attorney) Sometimes parties will enter a contract whereby one agrees to buy (or supply) all of
By: Jarod Bona (The Antitrust Attorney) Sometimes parties will enter a contract whereby one agrees to buy (or supply) all of
By: Tomasso Valletti (Pro Market) As you read this, please remember two numbers: 1,000 and zero. The former number represents
By: Steven C. Salop (Washington Center for Equitable Growth) The current U.S. economy is increasingly characterized by dominant firms controlling
By: Bill Baer & Caitlin Chin (Brookings Institution) At many points during the 2020 U.S. presidential election, social media platforms demonstrated
By: Ramsi Woodcock (What Am I Missing?) I, too, have been enamored of sports metaphors in antitrust. How can the level playing
By: Alden Abbott (Truth on the Market) The recent launch of the international Multilateral Pharmaceutical Merger Task Force (MPMTF) is just the latest
By: Tobias Pukropski (D’Kart) Antitrust has arguably become increasingly political in recent years. Tobias Pukropski provides an overview of the main developments
By: Bryan Cave Leighton & Paisner 2021 has been a busy year for antitrust legislation. On February 4, 2021, Senator
By: Agustín Reyna (Chilling Competition) [Chillin’Competition is publishing a series of posts featuring the views of various experts and stakeholders
By: Robert Connolly (Cartel Capers) In a prior post I listed a number of ideas I thought it would be useful
© Competition Policy International 2024